Podcast production built around MLR review, not around it.
Scientific credibility, policy conversation, and market access voice, produced on a schedule that already accounts for a 50-to-60-day review cycle.
Resonate Recordings produces Prescription for Better Access, a recurring show covering drug pricing, PBMs, and FDA policy for a pharma and biotech industry audience. The production schedule is built around MLR and fair balance review from the start — so a show doesn't stall waiting on a compliance sign-off nobody planned for.
Trusted by enterprise and pharma-adjacent brands
The companies behind shows we have produced.
MLR review isn't going away. The production schedule just has to plan for it.
MLR (Medical, Legal, Regulatory) review cycles commonly run 50 to 60 days per content piece at mid-to-large pharma companies. Most podcast agencies treat that as someone else's problem to solve after the episode is already recorded — which is exactly how a show quietly stalls for two months before its first release.
Resonate builds the review timeline into the production schedule from the first planning call, the same way we do for Prescription for Better Access, our recurring show for the pharma and biotech industry. Editorial, non-promotional content can often move faster by design; promotional content gets the runway MLR actually requires, planned in advance instead of discovered mid-production.
Talk to a Pharma Podcast Specialist →typical review timeline per content piece at mid-to-large pharma companies.
projected size of the MLR review software market by 2032, up from $13.1B in 2025.
Prescription for Better Access has run continuously since 2023 for the pharma and market access industry.
The year Resonate started producing podcasts for enterprise and regulated-industry clients.
What kind of show fits your organization's MLR reality?
The right format often depends on how much of it falls under full MLR promotional review versus editorial or policy content that clears faster. We help you pick a format that matches your review capacity, not just your content ambitions.
Policy & Market Access Shows
Cover drug pricing, PBMs, and affordability policy rather than specific product claims. This is the exact format behind Prescription for Better Access, and it typically clears review faster than promotional content because it isn't making product-specific claims.
Scientific Storytelling
Feature researchers and R&D teams discussing the science behind a therapeutic area in general terms. A scientific storytelling show builds credibility with clinicians and scientists without triggering full promotional MLR review.
Medical Affairs & Industry Commentary
A recurring show for medical affairs teams and business development audiences tracking industry trends, FDA policy, and competitive landscape. Internal or semi-public distribution keeps the review path lighter.
Product-Adjacent Promotional Series
For shows that do make product claims, a production schedule built around the full MLR and fair balance review timeline from day one, so the release calendar reflects reality instead of an assumption.
Everything your show needs. One MLR-aware partner.
Resonate offers the full pharma podcast stack, with production schedules built around MLR review timelines instead of assuming compliance will keep pace with a generic content calendar.
Podcast Launch
End-to-end launch that maps your MLR review timeline into the production schedule from day one, so a 50-to-60-day review cycle isn't a surprise before your first episode airs.
Learn moreAudio Production
Professional editing, mixing, and mastering for every episode. Degree-trained engineers, three to five business day turnaround, and a consistent process for a recurring show like Prescription for Better Access.
Learn moreVideo Production
YouTube-ready video cuts and short-form clips from every recording, built with fair balance and required risk information in mind for any product-adjacent content.
Learn morePodcast Management
A dedicated producer manages your show week to week, including scheduling around MLR submission windows and medical affairs calendars instead of working against them.
Learn morePodcast Marketing
Show notes, audiograms, and social cards, with required risk information and disclosure language built into every asset your marketing team publishes.
Learn morePrivate & Public Hosting
Public distribution to Apple, Spotify, and YouTube for industry-facing shows, or private, restricted-access hosting for internal medical affairs and R&D communication.
Learn morePrescription for Better Access, produced episode after episode.
Prescription for Better Access is co-hosted by Mark Hansan and Dr. Scott Howell, two industry veterans covering drug pricing, PBMs, patient access, and FDA policy for pharma, biotech, and market access audiences. Resonate has produced the show continuously since its 2023 launch, including live episodes recorded at industry events like Asembia's AXS Summit.
Talk to a Pharma Podcast Specialist →With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs, two industry veterans have joined forces to co-host an interview-focused podcast to help shape the future of patient access and affordability.
Pharma, policy, and enterprise podcasts produced by Resonate.
A real, ongoing pharma industry client, alongside enterprise internal-communications and practitioner formats that translate to medical affairs and R&D audiences.
Prescription for Better Access
A recurring interview show co-hosted by Mark Hansan and Dr. Scott Howell, covering drug pricing, PBMs, patient access, and FDA policy for a pharma and biotech industry audience. Produced by Resonate since its 2023 launch.
This is Resonate's clearest pharma-vertical credential: a real, ongoing client show built for exactly the policy and market access audience this page is written for.
Shared Practices — Your Dental Roadmap
A practitioner-focused show for dental professionals navigating practice ownership, growth, and transition. Produced by Resonate since launch, the show has built a loyal, returning audience within its niche.
Pharma and biotech teams can use this same practitioner-deep-dive format to build credibility with a clinical or scientific audience over time.
Better by Great Place to Work
A branded podcast for Great Place to Work, the global authority on workplace culture, interviewing executives and people leaders on building high-trust workplaces. Produced and managed end-to-end by Resonate.
Pharma and biotech organizations can use this same internal-communications model for R&D team storytelling and employee-facing content that sits outside promotional MLR review entirely.
Ready to build a show your MLR team can actually plan around?
Thirty minutes. We discuss your review process, your audience, and what an MLR-aware production schedule looks like for your show.
Common questions about pharma and biotech podcast production.
Everything you need to know before starting or scaling a podcast for your pharma, biotech, or market access organization.
Book an MLR-Aware Strategy Call →What is a pharma or biotech podcast?+
Does pharma podcast content need to go through MLR review?+
What does a pharma podcast production agency do?+
Can a pharma podcast discuss specific drugs or products?+
What kind of podcast should a pharma or biotech company launch?+
How much does pharma podcast production cost?+
How is a pharma podcast different from a general branded podcast?+
Has Resonate produced podcasts for pharma or biotech organizations specifically?+
Your MLR team already has a review timeline.
Let's build a show that plans around it, not against it.
Book a thirty-minute strategy call. We discuss your review process, your audience, and what an MLR-aware podcast looks like for your organization.
No commitment. Thirty minutes. Honest advice about whether podcasting is right for your organization right now.